Caribou Biosciences Inc. (CRBU)
NASDAQ: CRBU
· Real-Time Price · USD
2.84
0.40 (16.39%)
At close: Oct 15, 2025, 3:59 PM
2.83
-0.35%
After-hours: Oct 15, 2025, 07:43 PM EDT
Caribou Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 9.99M | 34.48M | 13.85M | 9.6M |
Cost of Revenue | 3.93M | 3.52M | 3.64M | 984K |
Gross Profit | 6.07M | 30.95M | 10.21M | 8.61M |
Operating Income | -166.62M | -116.06M | -106.4M | -66.98M |
Interest Income | n/a | 10.7M | 4.6M | 148K |
Pretax Income | -149.11M | -101.88M | -99.35M | -66.6M |
Net Income | -149.1M | -102.07M | -99.42M | -66.92M |
Selling & General & Admin | 46.46M | 38.46M | 38.02M | 24.32M |
Research & Development | 130.15M | 112.08M | 82.23M | 52.26M |
Other Expenses | -3.93M | -3.52M | -3.64M | -984K |
Operating Expenses | 172.68M | 147.01M | 116.61M | 75.59M |
Interest Expense | n/a | n/a | n/a | 8K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 176.61M | 150.54M | 120.25M | 76.58M |
Income Tax Expense | -9K | 193K | 70K | 321K |
Shares Outstanding (Basic) | 90.32M | 73.81M | 60.8M | 60.26M |
Shares Outstanding (Diluted) | 90.32M | 73.81M | 60.8M | 60.26M |
EPS (Basic) | -1.65 | -1.38 | -1.64 | -1.11 |
EPS (Diluted) | -1.65 | -1.38 | -1.64 | -1.11 |
EBITDA | -166.62M | -112.53M | -104.78M | -66M |
EBIT | -166.62M | -116.06M | -106.4M | -66.98M |
Depreciation & Amortization | 3.93M | 3.52M | 1.62M | 984K |
Source: Financial Modeling Prep. Financial Sources.